Regulation of Insulin Action by Protein Tyrosine Phosphatases

Vitamins and Hormones

Volumn 54, Issue C, 1998, Pages 67-96

  Goldstein, Barry J ^a   Li, Pei Ming ^a   Ding, Wendi ^a   Ahmad, Faiyaz ^a   Zhang, Wei Ren ^a  

^a Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; PROTEIN TYROSINE PHOSPHATASE;

ANIMAL; HUMAN; INSULIN RESISTANCE; METABOLISM; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; INSULIN; INSULIN RESISTANCE; PROTEIN-TYROSINE-PHOSPHATASE; SIGNAL TRANSDUCTION;

EID: 0031602585     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(08)60922-X     Document Type: Article

References (123)

1. Ahmad F., and Goldstein B.J. Purification, identification and subcellular distribution of three predominant protein-tyrosine phosphatase enzymes in skeletal muscle tissue. Biochim. Biophys. Acta 1248 (1995) 57-69
2. Ahmad F., and Goldstein B.J. Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model of obesity and insulin resistance. Metabolism 44 (1995) 1175-1184
3. Ahmad F., and Goldstein B.J. Alterations in specific protein-tyrosine phosphatases accompany the insulin resistance of streptozotocin-diabetes. Am. J. Physiol. 268 (1995) E932-E940
4. Ahmad F., and Goldstein B.J. Functional association between the insulin receptor and the transmembrane protein-tyrosine phosphatase LAR in intact cells. J. Biol. Chem. 272 (1997) 448-457
5. Ahmad F., Li P.M., Meyerovitch J., et al. Osmotic loading of neutralizing antibodies defines a role for protein-tyrosine phosphatase 1B in negative regulation of the insulin action pathway. J. Biol. Chem. 270 (1995) 20503-20508
6. Ahmad F., Considine R.V., and Goldstein B.J. Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects. J. Clin. Invest. 95 (1995) 2806-2812
7. Ahmad, F., Considine, R. V., Bauer, T. L., Ohannesian, J. P., Marco, C. C., and Goldstein, B. J. (1997a). Improved sensitivity to insulin in obese subjects following weight loss is accompanied by reduced protein-tyrosine phosphatases in adipose tissue. Metabolism, in press.
8. Ahmad F., Azevedo J.L., Cortright R., Dohm G.L., and Goldstein B.J. Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. J. Clin. Invest. 100 (1997) 449-458
9. Baass P.C., Diguglielmo G.M., Authier F., et al. Compartmentalized signal transduction by receptor tyrosine kinases. Trends Cell Biol. 5 (1995) 465-470
10. Backer J.M., Kahn C.R., and White M.F. Tyrosine phosphorylation of the insulin receptor during insulin-stimulated internalization in rat hepatoma cells. J. Biol. Chem. 264 (1989) 1694-1701
11. Begum N., Sussman K.E., and Draznin B. Differential effects of diabetes on adipocyte and liver phosphotyrosine and phosphoserine phosphatase activities. Diabetes 40 (1991) 1620-1629
12. Bernier M., Liotta A.S., Kole H.K., et al. Dynamic regulation of intact and C-terminal truncated insulin receptor phosphorylation in permeabilized cells. Biochemistry 33 (1994) 4343-4351
13. Bevan A.P., Burgess J.W., Drake P.G., et al. Selective activation of the rat hepatic endosomal insulin receptor kinase. Role for the endosome in insulin signaling. J. Biol. Chem. 270 (1995) 10784-10791
14. Bevan A.P., Drake P.G., Bergeron J.J.M., et al. Intracellular signal transduction: The role of endosomes. Trends Endocrinol. Metab. 7 (1996) 13-21
15. Boylan J.M., Brautigan D.L., Madden J., et al. Differential regulation of multiple hepatic protein tyrosine phosphatases in alloxan diabetic rats. J. Clin. Invest. 90 (1992) 174-179
16. Burgess J.W., Wada I., Ling N., et al. Decrease in β-subunit phosphotyrosine correlates with internalization and activation of the endosomal insulin receptor kinase. J. Biol. Chem. 267 (1992) 10077-10086
17. Caro J.F. Clinical review 26: Insulin resistance in obese and nonobese man. J. Clin. Endocrinol. Metab. 73 (1991) 691-695
18. Case R.D., Piccione E., Wolf G., et al. SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides. J. Biol. Chem. 269 (1994) 10467-10474
19. Charbonneau H., Tonks N.K., Kumar S., et al. Human placenta protein-tyrosine-phosphatase: Amino acid sequence and relationship to a family of receptor-like proteins. Proc. Natl. Acad. Sci. USA 86 (1989) 5252-5256
20. Charest A., Wagner J., Jacob S., et al. Phosphotyrosine-independent binding of Shc to the NPLH sequence of murine protein-tyrosine phosphatase-PEST-Evidence for extended phosphotyrosine binding phosphotyrosine interaction domain recognition specificity. J. Biol. Chem. 271 (1996) 8424-8429
21. Cheatham B., and Kahn C.R. Insulin action and the insulin signaling network. Endocr. Rev. 16 (1995) 117-142
22. Cicirelli M.F., Tonks N.K., Diltz C.D., et al. Microinjection of a protein-tyrosine-phosphatase inhibits insulin action in Xenopus oocytes. Proc. Natl. Acad. Sci. USA 87 (1990) 5514-5518
23. Cohen N., Halberstam M., Shlimovich P., et al. Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest. 95 (1995) 2501-2509
24. DeFronzo R.A., Bonadonna R.C., and Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15 (1992) 318-368
25. den Hertog J., Pals C.E.G.M., Peppelenbosch M.P., et al. Receptor protein tyrosine phosphatase-α activates pp60(c-src) and is involved in neuronal differentiation. EMBO J. 12 (1993) 3789-3798
26. den Hertog J., Tracy S., and Hunter T. Phosphorylation of receptor protein-tyrosine phosphatase a on Tyr789, a binding site for the SH3-SH2-SH3 adaptor protein GRB-2 in vivo. EMBO J. 13 (1994) 3020-3032
27. Ding W., Zhang W.R., Sullivan K., et al. Identification of protein-tyrosine phosphatases prevalent in adipocytes by molecular cloning. Biochem. Biophys. Res. Commun. 202 (1994) 902-907
28. Ebina Y., Ellis L., Jarnagin K., et al. Human insulin receptor cDNA: The structural basis for hormone activated transmembrane signaling. Cell 40 (1985) 747-758
29. Faure R., Baquiran G., Bergeron J.J.M., et al. The dephosphorylation of insulin and epidermal growth factor receptors. Role of endosome-associated phosphotyrosine phosphatase(s. J. Biol. Chem. 267 (1992) 11215-11221
30. Feener E.P., Backer J.M., King G.L., et al. Insulin stimulates serine and tyrosine phosphorylation in the juxtamembrane region of the insulin receptor. J. Biol. Chem. 268 (1993) 11256-11264
31. Fischer E.H., Charbonneau H., and Tonks N.K. Protein tyrosine phosphatases-A diverse family of intracellular and transmembrane enzymes. Science 253 (1991) 401-406
32. Flores-Riveros J.R., Sibley E., Kastelic T., et al. Substrate phosphorylation catalyzed by the insulin receptor tyrosine kinase. Kinetic correlation to autophosphorylation of specific sites in the beta subunit. J. Biol. Chem. 264 (1989) 21557-21572
33. Frangioni J.V., Beahm P.H., Shifrin V., et al. The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence. Cell 68 (1992) 545-560
34. Freeman R.M., Plutzky J., and Neel B.G. Identification of a human src homology 2-containing protein-tyrosine-phosphatase-A putative homolog of drosophila corkscrew. Proc. Natl. Acad. Sci. USA 89 (1992) 11239-11243
35. Freidenberg G.R., Reichart D., Olefsky J.M., et al. Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss. J. Clin. Invest. 82 (1988) 1398-1406
36. Friedman J.E., Dohm G.L., Leggettfrazier N., et al. Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss-Effect on muscle glucose transport and glucose transporter GLUT4. J. Clin. Invest. 89 (1992) 701-705
37. Goldfine A.B., Simonson D.C., Folli F., et al. Metabolic effects of sodium meta-vanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies. J. Clin. Endocrinol. Metab. 80 (1995) 3311-3320
38. Goldstein B.J. Regulation of insulin receptor signaling by protein-tyrosine dephosphorylation. Receptor 3 (1993) 1-15
39. Goldstein B.J. In: Sheterline P. (Ed). Protein Profile 2 (1995), Academic Press, London 1425-1585 Issue 13
40. Goldstein B.J. In: LeRoith D., Olefsky J.M., and Taylor S.I. (Eds). Diabetes Mellitus: A Fundamental and Clinical Text (1996), Lippincott, Philadelphia 174-186
41. Goldstein B.J., Meyerovitch J., Zhang W.R., et al. Hepatic protein-tyrosine phosphatases and their regulation in diabetes. Adv. Prot. Phosphatases 6 (1991) 1-17
42. Goldstein B.J., Zhang W.R., Hashimoto N., et al. Approaches to the molecular cloning of protein-tyrosine phosphatases in insulin-sensitive tissues. Mol. Cell. Biochem. 109 (1992) 107-113
43. Goren H.J., and Boland D. The 180,000 molecular weight plasma membrane insulin receptor substrate is a protein tyrosine phosphatase and is elevated in diabetic plasma membranes. Biochem. Biophys. Res. Commun. 180 (1991) 463-469
44. Gruppuso P.A., Boylan J.M., Posner B.I., et al. Hepatic protein phosphotyrosine phosphatase. Dephosphorylation of insulin and epidermal growth factor receptors in normal and alloxan diabetic rats. J. Clin. Invest. 85 (1990) 1754-1760
45. Gruppuso P.A., Boylan J.M., Smiley B.L., et al. Hepatic protein tyrosine phosphatases in the rat. Biochem. J. 274 (1991) 361-367
46. Habib T., Herrera R., and Decker S.J. Activators of protein kinase C stimulate association of Shc and the PEST tyrosine phosphatase. J. Biol. Chem. 269 (1994) 25243-25246
47. Haring H.U., Kasuga M., White M.F., et al. Phosphorylation and dephosphorylation of the insulin receptor: Evidence against an intrinsic phosphatase activity. Biochemistry 23 (1984) 3298-3306
48. Hashimoto N., and Goldstein B.J. Differential regulation of mRNAs encoding three protein-tyrosine phosphatases by insulin and activation of protein kinase C. Biochem. Biophys. Res. Commun. 188 (1992) 1305-1311
49. Hashimoto N., Feener E.P., Zhang W.R., et al. Insulin receptor protein-tyrosine phosphatases-Leukocyte common antigen-related phosphatase rapidly deactivates the insulin receptor kinase by preferential dephosphorylation of the receptor regulatory domain. J. Biol. Chem. 267 (1992) 13811-13814
50. Hashimoto N., Zhang W.R., and Goldstein B.J. Insulin receptor and epidermal growth factor receptor dephosphorylation by three major rat liver protein-tyrosine phosphatases expressed in a recombinant bacterial system. Biochem. J. 284 (1992) 569-576
51. Hauguel de Mouzon S., Peraldi P., Alengrin F., et al. Alteration of phosphotyrosine phosphatase activity in tissues from diabetic and pregnant rats. Endocrinology 132 (1993) 67-74
52. Hausdorff S.F., Bennett A.M., Neel B.G., et al. Different signaling roles of SH-PTP2 in insulin-induced GLUT1 expression and GLUT4 translocation. J. Biol. Chem. 270 (1995) 12965-12968
53. Ide R., Maegawa H., Kikkawa R., et al. High glucose condition activates protein tyrosine phosphatases and deactivates insulin receptor function in insulin sensitive rat 1 fibroblasts. Biochem. Biophys. Res. Commun. 201 (1994) 71-77
54. Kahn C.R. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43 (1994) 1066-1084
55. Kenner K.A., Hill D.E., Olefsky J.M., et al. Regulation of protein tyrosine phosphatases by insulin and insulin-like growth factor-I. J. Biol. Chem. 268 (1993) 25455-25462
56. Kenner K.A., Anyanwu E., Olefsky J.M., et al. Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-1 stimulated signaling. J. Biol. Chem. 271 (1996) 19810-19816
57. Khan M.N., Baquiran G., Brule C., et al. Internalization and activation of the rat liver insulin receptor kinase in vivo. J. Biol. Chem. 264 (1989) 12931-12940
58. King M.J., Sharma R.P., and Sale G.J. Site-specific dephosphorylation and de-activation of the human insulin receptor tyrosine kinase by particulate and soluble phosphotyrosyl protein phosphatases. Biochem. J. 275 (1991) 413-418
59. Klein H.H., Freidenberg G.R., Matthaei S., et al. Insulin receptor kinase following internalization in isolated rat adipocytes. J. Biol. Chem. 262 (1987) 10557-10564
60. Klip A., and Marette A. Acute and chronic signals controlling glucose transport in skeletal muscle. J. Cell. Biochem. 48 (1992) 51-60
61. Kowalski A., Gazzano H., Fehlmann M., et al. Dephosphorylation of the hepatic insulin receptor: Absence of intrinsic phosphatase activity in purified receptors. Biochem. Biophys. Res. Commun. 117 (1983) 885-893
62. Kublaoui B., Lee J., and Pilch P.F. Dynamics of signaling during insulin-stimulated endocytosis of its receptor in adipocytes. J. Biol. Chem. 270 (1995) 59-65
63. Kuhne M.R., Pawson T., Lienhard G.E., et al. The insulin receptor substrate-1 associates with the SH2-containing phosphotyrosine phosphatase Syp. J. Biol. Chem. 268 (1993) 11479-11481
64. Kuhne M.R., Zhao Z.Z., Rowles J., et al. Dephosphorylation of insulin receptor substrate 1 by the tyrosine phosphatase PTP2C. J. Biol. Chem. 269 (1994) 15833-15837
65. Kuhne M.R., Zhao Z.H., and Lienhard G.E. Evidence against dephosphorylation of insulin-elicited phosphotyrosine proteins in vivo by the phosphatase PTP2C. Biochem. Biophys. Res. Commun. 211 (1995) 190-197
66. Kulas D.T., Zhang W.R., Goldstein B.J., et al. Insulin receptor signaling is augmented by antisense inhibition of the protein-tyrosine phosphatase LAR. J. Biol. Chem. 270 (1995) 2435-2438
67. Kulas D.T., Goldstein B.J., and Mooney R.A. The transmembrane protein-tyrosine phosphatase LAR modulates signaling by multiple receptor tyrosine kinases. J. Biol. Chem. 271 (1996) 748-754
68. Kusari J., Kenner K.A., Suh K.I., et al. Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance. J. Clin. Invest. 93 (1994) 1156-1162
69. Lammers R., Bossenmaier B., Cool D.E., et al. Differential activities of protein tyrosine phosphatases in intact cells. J. Biol. Chem. 268 (1993) 22456-22462
70. Lechleider R.J., Sugimoto S., Bennett A.M., et al. Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine-1009, on the human platelet-derived growth factor receptor b. J. Biol. Chem. 268 (1993) 21478-21481
71. Lee J.P., Cho H., Bannwarth W., et al. NMR analysis of regioselectivity in dephosphorylation of a triphosphotyrosyl dodecapeptide autophosphorylation site of the insulin receptor by a catalytic fragment of LAR phosphotyrosine phosphatase. Prot. Sci. 1 (1992) 1353-1362
72. Lee J.S., and Pilch P.F. The insulin receptor-Structure, function, and signaling. Am J. Physiol. 266 (1994) C319-C334
73. Li P.M., Zhang W.R., and Goldstein B.J. Suppression of insulin receptor activation by overexpression of the protein-tyrosine phosphatase LAR in hepatoma cells. Cell. Signal. 8 (1996) 467-473
74. Maegawa H., Ugi S., Ishibashi O., et al. Src homology-2 domains of protein tyrosine phosphatase are phosphorylated by insulin receptor kinase and bind to the COOH-terminus of insulin receptors in vitro. Biochem. Biophys. Res. Commun. 194 (1993) 208-214
75. McGuire M.C., Fields R.M., Nyomba B.L., et al. Abnormal regulation of protein tyrosine phosphatase activities in skeletal muscle of insulin-resistant humans. Diabetes 40 (1991) 939-942
76. Meyerovitch J., Backer J.M., and Kahn C.R. Hepatic phosphotyrosine phosphatase activity and its alteration in diabetic rats. J. Clin. Invest. 84 (1989) 976-983
77. Meyerovitch J., Rothenberg P.L., Shechter Y., et al. Vanadate normalizes hyperglycemia in two mouse models of non-insulin dependent diabetes mellitus. J. Clin. Invest. 87 (1991) 1286-1294
78. Milarski K.L., and Saltiel A.R. Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin. J. Biol. Chem. 269 (1994) 21239-21243
79. Moller N.P.R., Moller K.B., Lammers R., et al. Selective down-regulation of the insulin receptor signal by protein-tyrosine phosphatases alpha and epsilon. J. Biol. Chem. 270 (1995) 23126-23131
80. Mooney R.A., and Anderson D.L. Phosphorylation of the insulin receptor in permeabilized adipocytes is coupled to a rapid dephosphorylation reaction. J. Biol. Chem. 264 (1989) 6850-6857
81. Nadiv O., Shinitzky M., Manu H., et al. Elevated protein tyrosine phosphatase activity and increased membrane viscosity are associated with impaired activation of the insulin receptor kinase in old rats. Biochem. J. 298 (1994) 443-450
82. Olichon-Berthe C., Hauguel deMouzon S., Peraldi P., et al. Insulin receptor dephosphorylation by phosphotyrosine phosphatases obtained from insulin-resistant obese mice. Diabetologia 37 (1994) 56-60
83. O'Neill T.J., Craparo A., and Gustafson T.A. Characterization of an interaction between insulin receptor substrate 1 and the insulin receptor by using the two-hybrid system. Mol. Cell. Biol. 14 (1994) 6433-6442
84. Pelicci G., Lanfrancone L., Grignani F., et al. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70 (1992) 93-104
85. Perkins L.A., Larsen I., and Perrimon N. corkscrew encodes a putative protein tyrosine phosphatase that functions to transduce the terminal signal from the receptor tyrosine kinase torso. Cell 70 (1992) 225-236
86. Posner B.I., Faure R., Burgess J.W., et al. Peroxovanadium compounds-A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics. J. Biol. Chem. 269 (1994) 4596-4604
87. Pot D.A., Woodford T.A., Remboutsika E., et al. Cloning, bacterial expression, purification, and characterization of the cytoplasmic domain of rat LAR, a receptor-like protein tyrosine phosphatase. J. Biol. Chem. 266 (1991) 19688-19696
88. Pronk G.J., McGlade J., Pelicci G., et al. Insulin-induced phosphorylation of the 46-kDa and 52-kDa Shc proteins. J. Biol. Chem. 268 (1993) 5748-5753
89. Reaven G.M. Role of insulin resistance in the pathophysiology of non-insulin dependent diabetes mellitus. Diabetes Metab. Rev. 9 (1993) 5S-12S Suppl. 1
90. Rosen O.M. After insulin binds. Science 237 (1987) 1452-1458
91. Sasaoka T., Draznin B., Leitner J.W., et al. Shc is the predominant signaling molecule coupling insulin receptors to activation of guanine nucleotide releasing factor and P21(Ras)-GTP formation. J. Biol. Chem. 269 (1994) 10734-10738
92. Seely B.L., Staubs P.A., Reichart D.R., et al. Protein tyrosine phosphatase 1B interacts with the activated insulin receptor. Diabetes 45 (1996) 1379-1385
93. Serra-Pages C., Saito H., and Streuli M. Mutational analysis of proprotein processing, subunit association, and shedding of the LAR transmembrane protein tyrosine phosphatase. J. Biol. Chem. 269 (1994) 23632-23641
94. Shechter Y. Insulin-mimetic effects of vanadate: Possible implications for future treatment of diabetes. Diabetes 39 (1990) 1-5
95. Shisheva A., Ikonomov O., and Shechter Y. The protein tyrosine phosphatase inhibitor, pervanadate, is a powerful antidiabetic agent in streptozotocin-treated diabetic rats. Endocrinolog 134 (1994) 507-510
96. Shoelson S.E., Chatterjee S., Chaudhuri M., et al. YMXM motifs of IRS-1 define substrate specificity of the insulin receptor kinase. Proc. Natl. Acad. Sci. USA 89 (1992) 2027-2031
97. Sredy J., Sawicki D.R., Flam B.R., et al. Insulin resistance is associated with abnormal dephosphorylation of a synthetic phosphopeptide corresponding to the major autophosphorylation sites of the insulin receptor. Metabolism 44 (1995) 1074-1081
98. Streuli M., Krueger N.X., Thai T., et al. Distinct functional roles of the two intracellular phosphatase like domains of the receptor-linked protein tyrosine phosphatases LCA and LAR. EMBO J. 9 (1990) 2399-2407
99. Streuli M., Krueger N.X., Ariniello P.D., et al. Expression of the receptor-linked protein tyrosine phosphatase LAR: Proteolytic cleavage and shedding of the CAM-like extracellular region. EMBO J. 11 (1992) 897-907
100. Sugimoto S., Lechleider R.J., Shoelson S.E., et al. Expression, purification, and characterization of SH2-containing protein tyrosine phosphatase, SH-PTP2. J. Biol. Chem. 268 (1993) 22771-22776
101. Sugimoto S., Wandless T.J., Shoelson S.E., et al. Activation of the SH2-containing protein tyrosine phosphatase, SH-PTP2, by phosphotyrosine-containing peptides derives from insulin receptor substrate-1. J. Biol. Chem. 269 (1994) 13614-13622
102. Sun X.J., Crimmins D.L., Myers M.G., et al. Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1. Mol. Cell. Biol. 13 (1993) 7418-7428
103. Sun X.J., Wang L.M., Zhang Y.T., et al. Role of IRS-2 in insulin and cytokine signaling. Nature 377 (1995) 173-177
104. Tavare J.M., and Siddle K. Mutational analysis of insulin receptor function-Consensus and controversy. Biochim. Biophys. Acta 1178 (1993) 21-39
105. Tonks N.K., Cicirelli M.F., Diltz C.D., et al. Effect of microinjection of a low-Mr human placenta protein tyrosine phosphatase on induction of meiotic cell division in Xenopus oocytes. Mol. Cell. Biol. 10 (1990) 458-463
106. Ugi S., Maegawa H., Olefsky J.M., et al. Src homology 2 domains of protein tyrosine phosphatase are associated in vitro with both the insulin receptor and insulin receptor substrate-1 via different phosphotyrosine motifs. FEBS Lett. 340 (1994) 216-220
107. Ugi S., Maegawa H., Kashiwagi A., et al. Expression of dominant negative mutant SH-PTP2 attenuates phosphatidylinositol 3′-kinase activity via modulation of phosphorylation of insulin receptor substrate-1. J. Biol. Chem. 271 (1996) 12595-12602
108. Vogel W., Lammers R., Huang J.T., et al. Activation of phosphotyrosine phosphatase by tyrosine phosphorylation. Science 259 (1993) 1611-1614
109. Walton K.M., and Dixon J.E. Protein tyrosine phosphatases. Annu. Rev. Biochem. 62 (1993) 101-120
110. White M.F., and Kahn C.R. The cascade of autophosphorylation in the β-sub-unit of the insulin receptor. J. Cell. Biochem. 39 (1989) 429-441
111. White M.F., Livingston J.N., Backer J.M., et al. Mutation of the insulin receptor at tyrosine 960 inhibits a signal transmission but does not affect its tyrosine kinase activity. Cell 54 (1988) 641-649
112. White M.F., Shoelson S.E., Keutmann H., et al. A cascade of tyrosine autophosphorylation in the β-subunit activates the phosphotransferase of the insulin receptor. J. Biol. Chem. 263 (1988) 2969-2980
113. Worm D., Handberg A., Hoppe E., et al. Decreased skeletal muscle phosphotyrosine phosphatase (PTPase) activity towards insulin receptors in insulin-resistant zucker rats measured by delayed europium fluorescence. Diabetologia 39 (1996) 142-148
114. Worm D., Vinten J., Staehr P., et al. Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle fractions from NIDDM patients compared with control subjects. Diabetologia 39 (1996) 1208-1214
115. Xiao S., Rose D.W., Sasaoka T., et al. Syp (SH-PTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction. J. Biol. Chem. 269 (1994) 21244-21248
116. Yamauchi K., Milarski K.L., Saltiel A.R., et al. Protein-tyrosine-phosphatase SH-PTP2 is a required positive effector for insulin downstream signaling. Proc. Natl. Acad. Sci. USA 92 (1995) 664-668
117. Yamauchi K., Ribon V., Saltiel A.R., et al. Identification of the major SH-PTP2-binding protein that is tyrosine phosphorylated in response to insulin. J. Biol. Chem. 270 (1995) 17716-17722
118. Yan P.F., Li S.L., Liang S.J., et al. The role of COOH-terminal and acidic domains in the activity and stability of human insulin receptor protein tyrosine kinase studied by purified deletion mutants of the beta-subunit domain. J. Biol. Chem. 268 (1993) 22444-22449
119. Yu Q., Lenardo T., and Weinberg R.A. The N-terminal and C-terminal domains of a receptor tyrosine phosphatase are associated by noncovalent linkage. Oncogene 7 (1992) 1051-1058
120. Zhang W.R., and Goldstein B.J. Identification of skeletal muscle protein-tyrosine phosphatases by amplification of conserved cDNA sequences. Biochem. Biophys. Res. Commun. 178 (1991) 1291-1297
121. Zhang W.R., Hashimoto N., Ahmad F., et al. Molecular cloning and expression of a unique receptor-like protein-tyrosine phosphatase in the leukocyte-common-antigen-related phosphatase family. Biochem. J. 302 (1994) 39-47
122. Zhang W.R., Li P.M., Oswald M.A., et al. Modulation of insulin signal transduction by eutopic overexpression of the receptor-type protein-tyrosine phosphatase LAR. Mol. Endocrinol. 10 (1996) 575-584
123. Zheng X.M., Wang Y., and Pallen C.J. Cell transformation and activation of pp60c-src by overexpression and activation of a protein tyrosine phosphatase. Nature 359 (1992) 336-339